{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_18364", "batch_size": 200, "batch_pos": 170, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain a high-potency verb, potent metaphor, or other Q2 alarmist cue.", "method": "llm_batch", "batch_id": "batch_2_9208", "batch_size": 200, "batch_pos": 133, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "Segment does not contain a moderate verb from the specified list paired with scale/impact.", "method": "llm_batch", "batch_id": "batch_3_13164", "batch_size": 200, "batch_pos": 71, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "No question is present in the segment.", "method": "llm_batch", "batch_id": "batch_4_11412", "batch_size": 200, "batch_pos": 65, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment discusses manufacturing capacity but lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_18468", "batch_size": 200, "batch_pos": 59, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain the 'minimiser + scale contrast' pattern.", "method": "llm_batch", "batch_id": "batch_6_5192", "batch_size": 200, "batch_pos": 12, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_20160", "batch_size": 200, "batch_pos": 190, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Discusses uncertainty about future manufacturing capability.", "method": "llm_batch", "batch_id": "batch_8_20988", "batch_size": 200, "batch_pos": 193, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
